Drug Pipeline

Iohexol Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
6
Active Studies
2
Recruiting
6
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-06-11 NCT07643467 Fluorescent Probe for Assessment of Renal Elimination Phase 4 Not Yet Recruiting
Active Studies by Phase
Phase 4
2
Phase 1
1
Not specified
3
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT06709521 Optimization of Beta-lactam Dosing in Critically Ill Patients With Cystatin C… Bacterial Infection Recruiting
NCT07643467 Fluorescent Probe for Assessment of Renal Elimination Augmented Renal Clearance Not Yet Recruiting
Phase 1
NCT03997370 Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast… Malignant Solid Neoplasm Active, Not Recruiting
Not specified
NCT07174440 Contrast and Anesthetic Level With Lumbar Erector Spinae Plan (ESP) Block Pain Recruiting
NCT07349797 MediBeacon® Transdermal GFR System for the Evaluation of Kidney Function in Adults With… Glomerular Filtration Rate Not Yet Recruiting
NCT05319990 Pathogenesis of Kidney Disease in Type 1 Diabetes: a Modern Kidney Biopsy Cohort (The… Type 1 Diabetes Active, Not Recruiting
Sponsors Running Iohexol Trials
NRG Oncology (1) University of Colorado, Denver (1) National Institute of Allergy and Infectious Diseases (NIAID) (1) University Hospitals Cleveland Medical Center (1) MediBeacon (1) Aaron Cook (1)
Disease Areas
Type 1 Diabetes (1) Diabetes (1) Chronic Kidney Disease (1) Heart Failure (1)
Get alerts when Iohexol trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free